167 related articles for article (PubMed ID: 33306079)
1. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.
Mei Y; Tang L; Xiao Q; Zhang Z; Zhang Z; Zang J; Zhou J; Wang Y; Wang W; Ren M
J Mater Chem B; 2021 Jan; 9(3):612-633. PubMed ID: 33306079
[TBL] [Abstract][Full Text] [Related]
2. Mimic Lipoproteins Responsive to Intratumoral pH and Allosteric Enzyme for Efficient Tumor Therapy.
Li J; Wang H; Xu J; Wu S; Han M; Li J; Wang Q; Ge Z
ACS Appl Mater Interfaces; 2022 Jan; 14(1):404-416. PubMed ID: 34962752
[TBL] [Abstract][Full Text] [Related]
3. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
4. Reconstituted high density lipoprotein-based nanoparticles: an overview of applications in regenerative medicine, preparation, evaluation and future trends.
Wang X; Zhou J; Wang W
Curr Pharm Des; 2015; 21(12):1529-44. PubMed ID: 25594411
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
Shahzad MM; Mangala LS; Han HD; Lu C; Bottsford-Miller J; Nishimura M; Mora EM; Lee JW; Stone RL; Pecot CV; Thanapprapasr D; Roh JW; Gaur P; Nair MP; Park YY; Sabnis N; Deavers MT; Lee JS; Ellis LM; Lopez-Berestein G; McConathy WJ; Prokai L; Lacko AG; Sood AK
Neoplasia; 2011 Apr; 13(4):309-19. PubMed ID: 21472135
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
[TBL] [Abstract][Full Text] [Related]
7. Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy.
Wang W; Chen K; Su Y; Zhang J; Li M; Zhou J
Biomacromolecules; 2018 Feb; 19(2):438-448. PubMed ID: 29334216
[TBL] [Abstract][Full Text] [Related]
8. Photophysical characterization of anticancer drug valrubicin in rHDL nanoparticles and its use as an imaging agent.
Shah S; Chib R; Raut S; Bermudez J; Sabnis N; Duggal D; Kimball JD; Lacko AG; Gryczynski Z; Gryczynski I
J Photochem Photobiol B; 2016 Feb; 155():60-5. PubMed ID: 26735001
[TBL] [Abstract][Full Text] [Related]
9. A Biocompatible Reconstituted High-Density Lipoprotein Nano-System as a Probe for Lung Cancer Detection.
Lu H; Zhang H; Zhang D; Lu H; Ma D
Med Sci Monit; 2015 Sep; 21():2726-33. PubMed ID: 26365043
[TBL] [Abstract][Full Text] [Related]
10. A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.
Li M; Su Y; Zhang F; Chen K; Xu X; Xu L; Zhou J; Wang W
Acta Biomater; 2018 Jul; 75():413-426. PubMed ID: 29859368
[TBL] [Abstract][Full Text] [Related]
11. Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy.
Ding Y; Wang Y; Opoku-Damoah Y; Wang C; Shen L; Yin L; Zhou J
Biomaterials; 2015 Dec; 72():90-103. PubMed ID: 26344366
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
Sabnis S; Sabnis NA; Raut S; Lacko AG
Int J Nanomedicine; 2017; 12():1453-1464. PubMed ID: 28260891
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape.
Huang JL; Jiang G; Song QX; Gu X; Song HH; Wang XL; Jiang D; Kang T; Feng XY; Jiang XG; Chen HZ; Gao XL
Pharmazie; 2016 Dec; 71(12):709-714. PubMed ID: 29441999
[TBL] [Abstract][Full Text] [Related]
14. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.
Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y
Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317
[TBL] [Abstract][Full Text] [Related]
15. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.
Wang J; Jia J; Liu J; He H; Zhang W; Li Z
Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of garcinia glycosides by reconstituted high-density lipoprotein nano-complexes.
Liu C; Zhou Z; Chen Y; Liu J; Wang Y; Liu H
J Microencapsul; 2018 Mar; 35(2):115-120. PubMed ID: 29195484
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-mimicking nanotherapeutics reconstituted with chenodeoxycholic acid modified protein for efficient tumor targeting.
Hu Y; Zou J; Wang Q; Chen Y; Wang H; Li J
Eur J Pharm Biopharm; 2024 Mar; 196():114184. PubMed ID: 38244896
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles.
Xiong F; Nirupama S; Sirsi SR; Lacko A; Hoyt K
Nanotheranostics; 2017; 1(4):440-449. PubMed ID: 29188177
[TBL] [Abstract][Full Text] [Related]
19. Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles.
Sabnis N; Nair M; Israel M; McConathy WJ; Lacko AG
Int J Nanomedicine; 2012; 7():975-83. PubMed ID: 22393294
[TBL] [Abstract][Full Text] [Related]
20. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
Kornmueller K; Vidakovic I; Prassl R
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
